Endocrine Abstracts

Cabergoline is a dopamine agonist that may be used as primary or adjunctive therapy for acromegaly. Although one study suggested biochemical control may be achieved in a substantial proportion of patients (Abs et al, JCEM 1998), it is still commonly perceived to be a relatively ineffective treatment, possibly on account of inadequate dosing.We performed a retrospective case notes review of 9 consecutive acromegalic patients to determine the effectiveness...

Thyroid cancer is the commonest malignancy seen in endocrine practice. Audits of clinical practice have revealed significant variations in management, and the British Thyroid Association have published guidelines (2002) to address this. The aim of our study was to assess the care-stage at which practice falls short of agreed standards. We performed retrospective case note review of 83 patients (72 female) followed in a specialist thyroid cancer clinic over 5 years. Histology d...

Differentiating aldosterone-producing adenomas (APA) from bilateral adrenal hyperplasia (BAH) as a cause of Conn’s syndrome (CS) is crucial for appropriate management. We have prospectively evaluated the relative contributions of PST, adrenal imaging by Computed Tomography (CT) and AVS in the differential diagnosis of CS.We investigated 25 consecutive patients with CS referred to our unit with an identical protocol. Every patient underwent PST, CT a...